Summary

Asia Pacific Ambulatory Cardiac Monitoring Devices Market is valued approximately at USD 1.80 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 12.34% over the forecast period 2024-2032. Ambulatory cardiac monitoring devices are portable devices that are used to constantly record the electrical activity of the heart as patients move about their regular routines. These gadgets include implanted loop recorders (ILR), event monitors, Holter monitors, and mobile cardiac telemetry (MCT)—which are crucial for identifying and treating cardiac disorders such as arrhythmias and unexplained fainting. They accurately record sporadic occurrences that may be overlooked in brief clinical examinations, supplying timely and precise data for early diagnosis. These technologies significantly boost the accuracy of cardiac diagnosis and treatments by enabling longer monitoring and patient mobility. The increase in adoption of telemedicine and Remote Patient Monitoring (RPM) solutions is growing across the region and is a key trend that is supporting the growth of the Asia Pacific Ambulatory Cardiac Monitoring Devices Market at a substantial rate. These distant healthcare models depend on ambulatory cardiac monitoring devices because they allow for continuous monitoring, early identification of cardiac problems, and improved patient outcomes particularly in rural locations.

The region's rapidly growing aging population is contributing to an growing prevalence of cardiac disorders, driving the demand for ambulatory monitoring solutions. Also, advancements in healthcare technology, such as miniaturization, wireless connectivity, and AI integration, are enhancing the capabilities and adoption of ambulatory cardiac monitoring devices across Asia Pacific. Additionally, there is a growing emphasis on remote patient monitoring (RPM) solutions, fueled by the adoption of telemedicine and the need for cost-effective healthcare delivery models. Governments across various Asia Pacific countries are implementing initiatives to enhance healthcare infrastructure and promote the adoption of advanced medical technologies. Regulatory frameworks are also evolving to ensure the safety, quality, and efficacy of ambulatory cardiac monitoring devices, fostering Asia Pacific Ambulatory Cardiac Monitoring Devices Market growth. However, ambulatory cardiac monitoring is expected to impede market growth due to its high cost and stringent regulatory environment over the projected period of 2024–2032.

The key Countries considered for the Asia Pacific Ambulatory Cardiac Monitoring Devices Market study includes China, India, Japan, South Korea, Australia and Rest of Asia Pacific. In 2023, China was the largest regional market in terms of revenue. China has a massive aging population, making it particularly susceptible to cardiac issues. This age group is more likely to require continuous monitoring for heart health, propelling the demand for ambulatory cardiac monitoring devices. Also, the Chinese government is prioritizing healthcare advancements. This includes favorable policies for developing and adopting medical technologies, potentially leading to increased affordability and accessibility of ambulatory cardiac monitoring devices. Whereas, the market in India is expected to develop at the fastest rate over the forecast period.

Major market player included in this report are:
Nihon Kohden Corporation
Fukuda Denshi
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
Company 4
Company 5
Company 6
Company 7
Company 8
Company 9
Company 10

The detailed segments and sub-segment of the market are explained below:

By Type
ECG Devices
Holter Monitors
Event Monitors
Implantable Loop Recorders
Mobile Cardiac Telemetry

By End-use
Ambulatory Care Centers
Hospitals & Clinics
Others

By Region:
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Years considered for the study are as follows:
Historical year – 2022
Base year – 2023
Forecast period – 2024 to 2032

Key Takeaways:
Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and country level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market

ページTOPに戻る

Table of Contents

Chapter 1. Asia Pacific Ambulatory Cardiac Monitoring Devices Market Definition and Research Assumptions
1.1. Research Objective
1.2. Market Definition
1.3. Research Assumptions
1.3.1. Inclusion & Exclusion
1.3.2. Limitations
1.3.3. Supply Side Analysis
1.3.3.1. Availability
1.3.3.2. Infrastructure
1.3.3.3. Regulatory Environment
1.3.3.4. Market Competition
1.3.3.5. Economic Viability (Consumer’s Perspective)
1.3.4. Demand Side Analysis
1.3.4.1. Regulatory frameworks
1.3.4.2. Technological Advancements
1.3.4.3. Environmental Considerations
1.3.4.4. Consumer Awareness & Acceptance
1.4. Estimation Methodology
1.5. Years Considered for the Study
1.6. Currency Conversion Rates

Chapter 2. Executive Summary
2.1. Asia Pacific Ambulatory Cardiac Monitoring Devices Market Size & Forecast (2022- 2032)
2.2. Regional Summary
2.3. Segmental Summary
2.3.1. By Type
2.3.2. By End-use
2.4. Key Trends
2.5. Recession Impact
2.6. Analyst Recommendation & Conclusion
Chapter 3. Asia Pacific Ambulatory Cardiac Monitoring Devices Market Dynamics
3.1. Market Drivers
3.2. Market Challenges
3.3. Market Opportunities
Chapter 4. Asia Pacific Ambulatory Cardiac Monitoring Devices Market: Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economic
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Asia Pacific Ambulatory Cardiac Monitoring Devices Market Size & Forecasts by Type 2022-2032
5.1. ECG Devices
5.2. Holter Monitors
5.3. Event Monitors
5.4. Implantable Loop Recorders
5.5. Mobile Cardiac Telemetry
Chapter 6. Asia Pacific Ambulatory Cardiac Monitoring Devices Market Size & Forecasts by End-use 2022-2032
6.1. Ambulatory Care Centers
6.2. Hospitals & Clinics
6.3. Others
Chapter 7. Asia Pacific Ambulatory Cardiac Monitoring Devices Market Size & Forecasts by Country 2022-2032
7.1. China Ambulatory Cardiac Monitoring Devices Market
7.1.1. Type breakdown size & forecasts, 2022-2032
7.1.2. End-use breakdown size & forecasts, 2022-2032
7.2. India Ambulatory Cardiac Monitoring Devices Market
7.3. Japan Ambulatory Cardiac Monitoring Devices Market
7.4. Australia Ambulatory Cardiac Monitoring Devices Market
7.5. South Korea Ambulatory Cardiac Monitoring Devices Market
7.6. Rest of Asia Pacific Ambulatory Cardiac Monitoring Devices Market
Chapter 8. Competitive Intelligence
8.1. Key Company SWOT Analysis
8.1.1. Company 1
8.1.2. Company 2
8.1.3. Company 3
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. Nihon Kohden Corporation
8.3.1.1. Key Information
8.3.1.2. Overview
8.3.1.3. Financial (Subject to Data Availability)
8.3.1.4. Product Summary
8.3.1.5. Market Strategies
8.3.2. Fukuda Denshi
8.3.3. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
8.3.4. Company 4
8.3.5. Company 5
8.3.6. Company 6
8.3.7. Company 7
8.3.8. Company 8
8.3.9. Company 9
8.3.10. Company 10
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes